secwatch.observer — SEC 8-K summary
======================================

Issuer:     AIM ImmunoTech Inc. (AIM)
CIK:        0000946644
Form:       8-K
Filed at:   2021-09-21T23:59:59+00:00
Accession:  0001493152-21-023270
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

AIM ImmunoTech CFO Ellen Lintal to retire effective March 31, 2022
------------------------------------------------------------------

- Ellen Lintal informed Company on Sept 20, 2021 of her retirement as CFO.
- Retirement and contract non-renewal effective March 31, 2022.
- Lintal will stay post-retirement on a contractual basis to assist with SEC filings.
- CFO departure timed to allow completion of annual report on Form 10-K.
- CEO Thomas K. Equels signed the filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/946644/000149315221023270/0001493152-21-023270-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/946644/000149315221023270/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-21-023270

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer